Literature DB >> 26225002

New Management Strategies of Oral Tongue Cancer in Bangladesh.

Jachmen Sultana1, Abul Bashar2, Motiur Rahman Molla3.   

Abstract

INTRODUCTION: Malignancies of the tongue represent one of the greatest management challenges for the maxillofacial surgeons as well as oncologists, because of the adverse effects of treatment on oral and pharyngeal function, the eventual quality of life, and the poor prognosis of advanced disease. Therefore, it is important to use judgment and experience in determining the best method of treatment.
MATERIAL AND METHODS: We reviewed forty cases of oral tongue cancer patients admitted in the Dental and Facio-Maxillary Surgical Oncology department in National Institute of Cancer Research and Hospital, and department of Oral and Maxillofacial Surgery, Dhaka Dental College and Hospital, Dhaka, Bangladesh, during the past four years and followed till the lesion healed or recurred and followed later on upto two years. All cases were thoroughly examined, investigated with routine blood examinations and radiography of the involved region. Preoperative biopsy of the lesion and staging was done in each and every case. Postoperative biopsy was taken where there was a doubt about the possibility of recurrence.
RESULTS: Squamous cell carcinoma (well differentiated) is by far the most common malignancy of the oral tongue. Generally a correlation is recognized between tumor size, nodal presence, metastasis, and eventual prognosis. When surgeons detect oral tongue cancer at an early stage, they can often treat it with surgery or can, often treat it with surgery or radiation. In later stages the cancer may require a combination of surgery, radiation and chemotherapy.
CONCLUSION: Standard and uniform protocol has not been explored till now for the practice in our country. So current management strategies of oral tongue cancer cannot be underestimated.

Entities:  

Keywords:  Bangladesh; Management; Oral Care; Prevention; Tongue Cancer

Year:  2013        PMID: 26225002      PMCID: PMC4518807          DOI: 10.1007/s12663-013-0566-8

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  6 in total

1.  A novel approach to advanced carcinoma of the tongue: cases successfully treated with combination of superselective intra-arterial chemotherapy and external/high-dose-rate interstitial radiotherapy.

Authors:  Takeshi Nishioka; Akihiro Homma; Yasushi Furuta; Hidefumi Aoyama; Fumiyuki Suzuki; Keiichi Ohmori; Takeshi Asano; Daisuke Yoshida; Hiroki Shirato; Satoshi Fukuda
Journal:  Jpn J Clin Oncol       Date:  2006-10-23       Impact factor: 3.019

2.  Treatment of oral postherpetic neuralgia with topical capsaicin.

Authors:  R J Hawk; L E Millikan
Journal:  Int J Dermatol       Date:  1988-06       Impact factor: 2.736

3.  The efficacy of chlorhexidine gel in reduction of Streptococcus mutans and Lactobacillus species in patients treated with radiation therapy.

Authors:  J B Epstein; B C McBride; P Stevenson-Moore; H Merilees; J Spinelli
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-02

4.  Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers.

Authors:  Koh-ichi Sakata; Masanori Someya; Hisayasu Nagakura; Kensei Nakata; Atushi Oouchi; Masaru Takagi; Masato Hareyama
Journal:  Jpn J Clin Oncol       Date:  2008-06       Impact factor: 3.019

5.  The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor.

Authors:  Masahiro Sakaguchi; Yoshihiro Kuroda; Munetaka Hirose
Journal:  Anesth Analg       Date:  2006-04       Impact factor: 5.108

6.  Brachytherapy of stage II mobile tongue carcinoma. Prediction of local control and QOL.

Authors:  Sayako Oota; Hitoshi Shibuya; Ryo-ichi Yoshimura; Hiroshi Watanabe; Masahiko Miura
Journal:  Radiat Oncol       Date:  2006-07-12       Impact factor: 3.481

  6 in total
  5 in total

Review 1.  The Anatomical Relationships of the Tongue with the Body System.

Authors:  Bruno Bordoni; Bruno Morabito; Roberto Mitrano; Marta Simonelli; Anastasia Toccafondi
Journal:  Cureus       Date:  2018-12-05

2.  In Situ Gel Loaded with Chitosan-Coated Simvastatin Nanoparticles: Promising Delivery for Effective Anti-Proliferative Activity against Tongue Carcinoma.

Authors:  Mallesh Kurakula; N Raghavendra Naveen
Journal:  Mar Drugs       Date:  2020-04-09       Impact factor: 5.118

3.  Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer.

Authors:  Fang Xiao; Yinhua Dai; Yujiao Hu; Mengmeng Lu; Qun Dai
Journal:  Cancer Cell Int       Date:  2019-11-21       Impact factor: 5.722

4.  Repurposing Lovastatin Cytotoxicity against the Tongue Carcinoma HSC3 Cell Line Using a Eucalyptus Oil-Based Nanoemulgel Carrier.

Authors:  Waleed Y Rizg; Khaled M Hosny; Samar S Mahmoud; Ahmed K Kammoun; Abdulmohsin J Alamoudi; Hossam H Tayeb; Haitham A Bukhary; Moutaz Y Badr; Samar S A Murshid; Eman Alfayez; Sarah A Ali; Rayan Y Mushtaq; Walaa A Abualsunun
Journal:  Gels       Date:  2022-03-12

5.  Levofloxacin might be safe to use for OSCC patients.

Authors:  Levent Aydemir; Elif Sinem Iplik; Baris Ertugrul; Goksu Kasarci; Merve Nur Atas; Murat Ulusan; Arzu Ergen; Bedia Cakmakoglu
Journal:  Med Oncol       Date:  2021-06-25       Impact factor: 3.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.